Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19

Background and aims: Favipiravir is a ribonucleic acid (RNA)-dependent RNA polymerase (RdRP) inhibitor antiviral agent used in the treatment of coronavirus disease-2019 (COVID-19). In this study, we investigated the changes in serum transaminase levels of patients and the relationship between serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayram, Mehmet, Yildirim, Ozgur, Ozmen, Raye Sevra, Soylu, Beyza, Dundar, Ahmet Said, Koksal, Ali Riza, Akarsu, Murat, Kumbasar, Abdulbaki, Tabak, Omur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530246/
https://www.ncbi.nlm.nih.gov/pubmed/34703696
http://dx.doi.org/10.7759/cureus.18166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530246/
https://www.ncbi.nlm.nih.gov/pubmed/34703696
http://dx.doi.org/10.7759/cureus.18166

Ejemplares similares